alpha-Defensins
Showing 1 - 25 of 2,682
Analysis of Intestinal Defensin Expression in Acute GVHD
Active, not recruiting
- GVHD,Acute
- +2 more
-
Freiburg, Baden-Württemberg, GermanyMedical Center University of Freiburg
Nov 3, 2021
Periorbital Wrinkles Trial in San Diego (enhanced DefenAge 8-in-1 BioSerum)
Recruiting
- Periorbital Wrinkles
- enhanced DefenAge 8-in-1 BioSerum
-
San Diego, CaliforniaWest Dermatology Research Center/Cosmetic Laser Dermatology
Oct 26, 2021
Neonatal Sepsis Trial in Milano (Preterm Infants - fed fermented formula, Preterm Infants - fed standard formula, Pre-term
Recruiting
- Neonatal Sepsis
- Preterm Infants - fed fermented formula
- +2 more
-
Milano, ItalyUnità di Neonatologia e Terapia Intensiva Neonatale, Clinica Ma
Jun 1, 2022
Etiology of Eczema Herpeticum (EH)
Completed
- Eczema Herpeticum
-
Denver, ColoradoNational Jewish Health: Division of Pediatric Allergy and Clinic
Jan 13, 2021
COVID-19 Trial in Orange (ORTD-1 low dose, ORTD-1 mid dose, ORTD-1 high dose)
Withdrawn
- COVID-19
- ORTD-1 low dose
- +3 more
-
Orange, CaliforniaUC Irvine Medical Center
Jun 9, 2021
Screening for Alpha Thalassemia in Healthy Volunteers
Recruiting
- Alpha Thalassemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Frontal Alpha Asymmetry and Pediatric Emergence Delirium
Not yet recruiting
- Emergence Delirium
- Ophthalmic surgery
- General anesthesia
- (no location specified)
Apr 5, 2023
Alpha-1 Antitrypsin Deficiency Trial in Gainesville (Alpha-1 Antitrypsin Genotype)
Recruiting
- Alpha-1 Antitrypsin Deficiency
- Alpha-1 Antitrypsin Genotype
-
Gainesville, FloridaUniversity of Florida
Nov 2, 2022
Allergic Bronchiolitis Trial (Serum)
Not yet recruiting
- Allergic Bronchiolitis
- Serum
- (no location specified)
Nov 14, 2023
Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)
Completed
- Rheumatoid Arthritis
- ISIS 104838
-
Birmingham, Alabama
- +30 more
Dec 1, 2022
Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- DaRT seeds insertion
- (no location specified)
Sep 5, 2023
Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- (no location specified)
Jul 28, 2023
Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in
Not yet recruiting
- Brain Ischemia
- Serum Iron
- +7 more
-
Aswan, EgyptAswan University Hospital
Mar 7, 2023
Kidney Transplant Trial in Canada, United States (Infliximab, Methylprednisolone, Mycophenolate Mofetil)
Completed
- Kidney Transplant
- Infliximab
- +9 more
-
Birmingham, Alabama
- +14 more
Jul 19, 2022
Alpha-Thalassemia, Alpha Thalassemia Major, Alpha Thalassemia Minor Trial in San Francisco
Recruiting
- Alpha-Thalassemia
- +2 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Oct 7, 2022
Vestibular Function Disorder Trial in San Antonio (Alpha Lipoic Acid 300mg, Coenzyme Q10 200mg)
Not yet recruiting
- Vestibular Function Disorder
- Alpha Lipoic Acid 300mg
- Coenzyme Q10 200mg
-
San Antonio, TexasUniversity of Texas Health Science Center at San Antonio
Jul 5, 2023
Ischemic Cardiomyopathy, Diabetes Trial in Damanhur (Alpha Lipoic Acid 600 MG Oral Tablet, Placebo Tablet)
Recruiting
- Ischemic Cardiomyopathy
- Diabetes Mellitus
- Alpha Lipoic Acid 600 MG Oral Tablet
- Placebo Tablet
-
Damanhūr, Elbehairah, EgyptDamanhour Teaching Hospital, General Organization for Teaching H
Sep 26, 2023
Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and
Recruiting
- Lymphomatoid Granulomatosis
- +3 more
- Interferon
- Rituxan and EPOCH
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Dexmedetomidine, Propofol, Mechanical Ventilation Trial in Tanta (Dexmedetomidine, Propofol)
Recruiting
- Dexmedetomidine
- +4 more
-
Tanta, El-Gharbia, EgyptTanta University
Oct 24, 2023
European Alpha-Mannosidosis Participant
Terminated
- Immunodeficiency
- +5 more
-
Aachen, Germany
- +18 more
Jun 10, 2022
GVHD Trial in Hackensack (Telmisartan)
Active, not recruiting
- GVHD
-
Hackensack, New JerseyHackensack University Medical Center
Sep 2, 2022
Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)
Recruiting
- Metabolic Associated Fatty Liver Disease
- LUDLEV®300 mg/46.2 mg
- Placebo
-
Mexico, Veracruz, MexicoAna Delfina Cano Contreras
Jun 12, 2023